Phreesia (NYSE:PHR) Price Target Raised to $35.00

Phreesia (NYSE:PHR) had its price objective lifted by equities researchers at Citigroup from $31.00 to $35.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s target price suggests a potential upside of 33.13% from the stock’s previous close.

PHR has been the topic of a number of other reports. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $24.00 to $32.00 in a research note on Wednesday. Truist Financial lifted their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. KeyCorp raised their target price on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Friday. Finally, Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $31.00.

Phreesia Trading Down 7.5 %

Shares of Phreesia stock traded down $2.14 during trading hours on Friday, hitting $26.29. The company’s stock had a trading volume of 339,092 shares, compared to its average volume of 397,586. The business has a fifty day moving average of $22.70 and a 200 day moving average of $22.57. Phreesia has a 1-year low of $17.07 and a 1-year high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.53 billion, a PE ratio of -17.88 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.58) EPS. As a group, equities analysts forecast that Phreesia will post -1.16 EPS for the current year.

Insider Transactions at Phreesia

In other news, General Counsel Allison C. Hoffman sold 1,212 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $25,488.36. Following the completion of the sale, the general counsel now directly owns 119,791 shares of the company’s stock, valued at approximately $2,519,204.73. This represents a 1.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Yvonne Hui sold 2,791 shares of the company’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the transaction, the insider now owns 27,228 shares of the company’s stock, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 101,703 shares of company stock worth $2,343,541. 5.80% of the stock is owned by corporate insiders.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the stock. International Assets Investment Management LLC lifted its stake in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new position in Phreesia during the second quarter worth $202,000. Point72 DIFC Ltd bought a new position in Phreesia in the second quarter valued at $209,000. XTX Topco Ltd acquired a new stake in Phreesia in the 3rd quarter valued at $247,000. Finally, Hsbc Holdings PLC bought a new stake in Phreesia during the 2nd quarter worth about $301,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.